Cis-and trans-acting elements of the Escherichia coli lac operon were transferred to vaccinia virus and used to regulate gene expression. A recombinant virus that constitutively expresses a modified lac repressor gene (lacl) was constructed. We calculated that each infected cell contained =2
x 107 active repressor molecules (and 1-2 x 104 copies of the vaccinia virus genome). A strong vaccinia-virus late promoter was modified by insertion of the lac operator (lacO) at various positions. The ability of each modified promoter to regulate expression of (3-galactosidase was tested by transient assays in cells infected with wild-type or lacI-containing vaccinia virus. Placement of the lacO just downstream of the conserved TAAAT sequence of a late promoter was consistent with a miinimal effect on basal expression and good repressibility, whereas basal expression was severely inhibited when IacO overlapped or preceded the TAAAT motif. A single recombinant vaccinia virus containing Ila and the f-galactosidase gene under control of the optimal bacO promoter was constructed. In the absence of inducer, cells infected with this double recombinant virus synthesized little or no detectable (3-galactosidase. Addition of isopropyl fi-D-thiogalactoside restored expression to >20% of the unrepressed level. This inducible vector system has potential applications for expression of heterologous and homologous genes.
Vaccinia virus has been developed as a vector for expression of heterologous genes (1) (2) (3) . The availability of plasmid transfer vectors containing a vaccinia virus promoter, sites for insertion of foreign genes, and a variety of markers for selection and/or screening of recombinant plaques (4) (5) (6) has facilitated the use of this system. With the appropriate choice of vaccinia virus promoters, inserted genes can be expressed during the entire growth cycle ofthe virus or only during early or late phases. Expression of bacteriophage 17 RNA polymerase by vaccinia virus has allowed selective high-level transcription of genes that have been engineered to contain a T7 promoter and are present in either a transfected plasmid (7) or a second coinfected virus (8) . Still missing from vaccinia virus vectors, however, is the capability of inducing specific gene expression on command. In the absence of any known naturally inducible vaccinia virus promoter, we considered the importation of one from eukaryotic or prokaryotic sources. Of the latter, we chose to explore the use of the operator/repressor system of the Escherichia coli lactose operon (9) because it is well characterized, exhibits both stringent repression and high inducibility, and has been adapted to mammalian cells (10) (11) (12) (11) into pGS53 (8) . The series of recombinant plasmids, placOZ-1, placOZ-2, and placOZ-3, were derived from a parent vector designated pMJ11 (received from A. J. Davison, University of Glasgow). Plasmid pMJ11 contains the vaccinia virus thymidine kinase (TK) DNA sequence inserted into a pUC-based vector. The TK sequence was bisected by cleavage with EcoRI into which a lacZ gene was inserted with the following polylinker sequence: 5'-GGATCC ,GTCGAC ,AAGCTT ,GGTACC ,CTCGAG, CATG-3'. The six nucleotide sets correspond to restriction endonucleases BamHI, Sal I, HindIII, Kpn I, and Xho I, respectively. The ATG represents the first codon of the lacZ coding sequence. Plasmid pMJ11 was cleaved sequentially with HindIII and Xho I into which a set of oligonucleotides were inserted. These oligonucleotides reconstructed the vaccinia virus late promoter, P11, with lacO interposed in three different positions (see Fig. 3 ). The oligonucleotides used for placOZ-1 were PE1, PE2, PE3, and PE4; the oligonucleotides used for placOZ-2 were PE1, PE2, PE5, and PE6; and the oligonucleotides used for placOZ-3 were PE1, tTo whom reprint requests should be addressed.
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RESULTS

Construction of a Recombinant Vaccinia
Virus That Expresses the lac Gene. A modified lacI gene, in which the natural GUG translation initiation codon was replaced by AUG (11) , was inserted into the transfer vector pGS53 (8) so that it was (i) adjacent to the vaccinia virus P7.5 promoter, which would ensure both early and late expression (17) and (ii) between the left and right halves of the vaccinia virus TK gene (Fig. 1A) . The resulting plasmid, placI, was used to transfect CV-1 cells that were also infected with vaccinia virus. Recombinant virus was then selected by plaque assay on TK-cells in the presence of 5-bromodeoxyuridine and distinguished from spontaneous TK-mutants by dot-blot hybridization to a lacI DNA probe (4). A recombinant virus, designated vlacl, was purified, and the correct insertion of the lac repressor into the TK gene was confirmed by Southern blot hybridization.
Evidence was obtained that lacI was expressed by the recombinant vaccinia virus. Extracts from cells that were infected with vlacI or wild-type vaccinia virus were dissociated with SDS and analyzed by polyacrylamide gel electrophoresis. An immunoblot was performed using an anti-lac repressor mouse monoclonal antibody (18) . The autoradiogram (Fig. 1B ) revealed a single immunoreactive band, of -38 kDa, which comigrated with authentic lac repressor.
The ability of the lac repressor, made by recombinant vaccinia virus, to bind to its cognate operator sequence in vitro was tested by a gel-mobility-band shift assay. A radioactively labeled synthetic operator containing the sequence GAATTGTGAGCGCTCACAATTC (19) and its complement were prepared by hybridizing oligonucleotides PE7 and PE8 together and filling in the nonoverlapping nucleotides with [a-32P]dCTP. The 41-base-pair (bp) probe was incubated with varying dilutions of extracts made from cells that had been infected with vlacl or wild-type virus. In the presence of extracts from vlacl-infected cells, the mobility of the probe was retarded (Fig. 2) . Moreover, the latter protein-DNA complex comigrated with the complex formed from the association of authentic lac repressor with the probe. (20, 21) suggested that only a relatively short sequence preceding the highly conserved TAAAT motif (22) of late promoters was required for transcription. The RNA start site is apparently located within the TAAAT sequence, and any variation of these nucleotides impairs expression (A. J. Davison and B.M., unpublished work). It seemed likely, therefore, that binding of repressor close to the TAAAT sequence would have the desired regulatory effect.
,B-galactosidase (encoded by the E. coli lacZ gene) was chosen as a reporter because there is no detectable background activity in mammalian cells and the assay is quantitative (5) .
The late promoter for the gene encoding the 11-kDa structural protein is typical in that the conserved TAAAT motif is followed immediately by a guanosine that completes CV-1 cells were infected with vlacI or wild-type vaccinia virus at a multiplicity of infection (moi) of 15. Cells were harvested 24 hr after infection, and cytoplasmic fractions were prepared by Dounce homogenization in hypotonic buffer (10 mM Tris HCI, pH 7.6/10mM NaCI/1.5 mM MgCl2). Nuclei and cell debris were removed by centrifugation, and either undiluted or diluted samples (1 p.1) of vlacl extracts were mixed with 32P-labeled, double-stranded oligonucleotide probe and 50 mM poly(dIdC). Similarly, undiluted wild-type virus-infected cell extract and various amounts of purified E. coli lac repressor protein were mixed with probe and poly(dIdC) to serve as negative and positive controls, respectively. The samples were separated by 8% polyacrylamide gel electrophoresis and exposed to x-ray film. Arrow, lac repressor DNA.
the translation initiation codon. To facilitate construction, it was important to move the translation initiation codon further downstream. Although the presence of a guanosine immediately following TAAAT is not essential for late transcription, substitution of other nucleotides may lower expression (A. J. Davison and B.M., unpublished work). The TAAATG sequence was retained in the lacZfusion gene ofplasmid pSC11 (Fig. 3) . In plasmid placOZ-1, however, the guanosine was changed to an adenosine, and this was followed by a 22-bp lacO palindrome, a new translation initiation codon, and the lacZ open reading frame. Plasmid placOZ-2 is similar, except that lacO overlaps the TAAAT motif, which is followed by a ribosylthymine. In plasmid placOZ-3, lacO precedes the TAAAT motif, which is followed by an adenosine and the lacZ open reading frame. The effects of the above mutations on promoter function were tested by transfecting the plasmids into CV-1 cells that had been infected with wild-type vaccinia virus and subsequently assaying lysates forB-galactosidase activity. In Fig.  3 , the values are presented as the percent of activity obtained with plasmid pSC11 in which the late promoter has been unperturbed. Placement of the operator immediately downstream of the TAAAT box without (placOZ-1) or with (placOZ-2) a slight overlap resulted in 66% and 20% of ,3-galactosidase activity, respectively. These differences might be due, at least in part, to the change in the nucleotide following the ribosylthymine from guanosine to adenosine in one case and to ribosylthymine in the other. Placement of the operator immediately upstream of the TAAAT box (placOZ-3) completely abolished the expression of f3-galactosidase, presumably by interrupting the promoter sequence.
To see whether the promoters were under lacO control, similar transfections were performed with cells that were infected with the recombinant vaccinia virus, vlacl, which expresses the lac repressor. In the absence of IPTG, no P-galactosidase activity was detected, suggesting stringent repression. With IPTG the f-galactosidase activity obtained with placOZ-1 was 8.3% of pSC11 or 12.5% of the value obtained with placOZ-1 in cells infected with wild-type vaccinia virus (Fig. 3) . Significant, although low, P-galactosidase levels were achieved with placOZ-2 and vlacI in the presence of IPTG (Fig. 3) . ing the transcriptional regulatory cassette so that recombination with wild-type virus could be carried out to form vlacOZ-1 as the next step.
Coinfection of Cells with Recombinant Viruses
We tested repression and induction by coinfecting cells with vlacl and vlacOZ-1. The level of repression was affected by the ratio of viruses containing lacI and lacO (Fig. 4) . At 1:1 repression was 97% and increased to >99% at a ratio of 2:1. At 10:1 no f-galactosidase activity could be detected.
IPTG, however, increased P-galactosidase expression >15-fold. As anticipated, only a minor diminution in expression occurred when the ratio of wild-type vaccinia virus to vlacOZ-1 was increased, and IPTG had no effect on this.
Construction of a Single Recombinant Vaccinia Virus Containing lac and lacO Elements. The next step in the development of vaccinia virus as an inducible vector was to incorporate both the repressor and operator sequences into the same virus. A new transfer vector was constructed and used to prepare a TK-recombinant virus designated vlacI/ OZ-1 (Fig. SB) . Initial experiments revealed that vlacI/OZ-1 plaques did not stain blue when the chromogenic JOgalactosidase substrate 5-bromo-4-chloro-3-indolyl P-Dgalactoside (X-Gal) was added to the agar, whereas vlacOZ-1 plaques were intensely blue when incubated for half the vlacI/OZ-1 time exposure (Fig. 5) The effect of 1acO on the basal (unrepressed) level of promoter activity depended on its location. When the operator was placed just downstream of the conserved TAAAT late-promoter sequence, expression was reduced 34%, whereas overlapping of the TAAAT sequence with 1acO led to an 80%o reduction. Transient expression experiments demonstrated that lac repressor inhibited expression from both of these hybrid promoters and that IPTG partially overcame this inhibition. Placement of the operator just upstream of the TAAAT sequence evidently destroyed the promoter, because no expression was detected. Based on these experiments, we concentrated on the hybrid promoter in which the operator was located just downstream of the TAAAT motif. The role, if any, of the weak secondary operator element within the lacZ gene (23) was not evaluated. In E. coli, operator binding of lac repressor appears to inhibit the formation of a stable open complex between RNA polymerase and the lac promoter (24) . Preliminary nuclease S1 analysis indicated that f3-galactosidase transcripts were not detected in cells infected with the recombinant vaccinia virus expressing repressor unless IPTG was added (T.R.F., unpublished work); however, additional studies are needed to prove the mechanism of repressor action in the vacciniavirus system.
We can envision several important uses of the lac operator/repressor system in vaccinia virus. It should now be possible to clone into vaccinia virus toxic genes that will be expressed only on command-e.g., upon addition of inducer. Another use may be to regulate the expression of essential genes of vaccinia virus and thereby to study their roles. In this manner, it should be possible to make conditionally lethal (IPTG-dependent) virus mutants. The E. coli lac repressor/ operator system could be readily transferred to other large DNA viruses, such as adenoviruses or herpesviruses; however, these viruses replicate in the nucleus and therefore it might be advantageous to add nuclear localization sequences to the repressor.
